Skip to main content

Month: November 2024

Invesco Ltd: Form 8.3 – Loungers PLC; Opening Position disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Loungers PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior to...

Continue reading

Invesco Ltd: Form 8.3 – Direct Line Insurance Group PLC; Opening Position disclosure

FORM 8.3 OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Direct Line Insurance Group PLC  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable...

Continue reading

Medical Robots Market to Witness Massive Growth at USD 34.32 Billion by 2031 | SkyQuest Technology

Westford, USA, Nov. 29, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the medical robot market will attain a value of USD 34.32 Billion by 2031, with a CAGR of 17.4 % during the forecast period (2024-2031). The rising incidence of diseases such as cancer, neurological disorders, and orthopedic neck & spine conditions will create demand for accuracy surgical procedures particularly in the aging population segment, fueling medical robots market growth. Increasing numbers of geriatric patients undergoing surgical procedures also boosts market growth. Ideal for patients and healthcare professionals alike, robotic surgical procedures offer better advantages over traditional open surgeries that can include less pain, shorter recovery times, and decreased complication rates. Compared to traditional techniques, robotic systems provide...

Continue reading

Avricore Health Corporate Update: Effective Plan, Resources Result in Success

VANCOUVER, British Columbia, Nov. 29, 2024 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “Avricore”) reports on its third quarter results for 2024 where the Company continues to see rising revenues and profitability.In the nine months ended September 30, 2024, revenue increased by 58% year over year to $3,364,635 and gross profit increased by 84% to $1,290,357. In the three months ended September 30, 2024, revenue increased by 25% year over year to $1,195,122 and gross profit increased by 66% to $434,791. In the nine months ended September 30, 2024, the Company recorded net profit of $43,494 and a net increase in cash of $503,994.“The global healthcare landscape is rapidly evolving and HealthTab™ is uniquely positioned to play a critical role in the future of community-based care,” said Hector...

Continue reading

Pasinex Announces Filing of 2024 Third Quarter Financial Results

TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE) (FSE: PNX) (The “Company” or “Pasinex”) announces that the Company has filed its financial statements, management’s discussion and analysis, and related certifications for the three and nine months ended September 30, 2024 (collectively, the “Third Quarter Results”) on SEDAR+. Second Quarter Financial Results Cautionary Note The Company has not completed a current technical report that includes a mineral resource estimate as defined by the Mineral Resources and Reserves, Definitions and Guidelines prepared by the CIM Standing Committee on Reserve Definitions and adopted by CIM Council, and procedures for classifying the reported Mineral Resources were undertaken within the context of the Canadian Securities Administrators National Instrument 43-101...

Continue reading

Entourage Health Reports Strong Third Quarter 2024 Financial Results

The Company achieved a total revenue of $13.6 million. Gross Profit Margins continue to demonstrate a solid performance with 30% growth year-over-year. SG&A achieves a significant reduction, reflecting the Company’s notable 32% decrease year-over-year. EBITDA improves by 70% for the quarter and 65% year-over-year, reflecting progress toward profitability. Management will host a conference call on November 29, 2024, at 10 a.m. Eastern Time.TORONTO, Nov. 29, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V:ENTG) (OTCQX:ETRGF) (FSE:4WE) (“Entourage” or the “Company”), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the three and nine months ended September 30, 2024. The Company will host a conference call to discuss its financial and business highlights...

Continue reading

CURRENC Group Inc. Announces Third Quarter 2024 Unaudited Financial Results

SINGAPORE, Nov. 29, 2024 (GLOBE NEWSWIRE) — CURRENC Group Inc. (Nasdaq: CURR) (“CURRENC” or the “Company”), a fintech and digital remittance pioneer serving millions of unbanked and underbanked individuals in Southeast Asia and beyond, recently announced its unaudited financial results for the third quarter ended September 30, 2024. Third Quarter and First Nine Months 2024 Financial HighlightsTotal Processing Value (TPV) was US$1.21 billion for the third quarter and US$3.92 billion for the first nine months of 2024, increasing by 6.1% and 18.8% year over year, respectively.   Total revenues (contributed by subsidiaries Tranglo, WalletKu, TNG Asia and GEA,1 as well as other services) were US$11.3 million for the third quarter and US$35.4 million for the first nine months of 2024, representing year-over-year decreases of 11.0%...

Continue reading

Rivalry Reports Third Quarter 2024 Results; Rivalry Token Momentum Leading Company’s Crypto-Native Future; Reveals Organizational Realignment, Major Product Revamp

Rivalry Token Captures $3.0 Million in Deferred Revenue; Company Executes Significant Organizational Realignment Throughout the Third Quarter to Reposition Product, Brand, and Team for Crypto Gambling Market; Delivers Substantial Reduction in Operational Expenses; Closes Second Tranche of Non-Brokered Private Placement for $1.0 MillionAs of today, the Company has completed the largest product, brand, and marketing overhaul in its history to support a global, crypto-first strategy and maximize wallet share of high value players (“HVP’s”). Average net revenue per user has hit all-time records, increasing by 51% as compared to the average of the trailing 2024 period, and by 70% as compared to the trailing three-year average since launching the initial set of new product features in October. Rivalry’s current run rate operating expenses...

Continue reading

Hyperscale Data Announces 640 Bitcoin Mined Year to Date

LAS VEGAS, Nov. 29, 2024 (GLOBE NEWSWIRE) — Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data,” or the “Company”), today announced that it has mined 640 Bitcoin year to date through November 26, 2024. Of this total, approximately 380 were mined at the Company’s facility in Michigan, with the remaining approximately 260 Bitcoin from mining machines previously hosted by Core Scientific, Inc.William B. Horne, CEO of Hyperscale Data, stated, “While the Company is transitioning to a pure play artificial intelligence data center business, we remain pleased with our past and current Bitcoin mining operations. We are committed to keeping our stockholders informed as we make the transition into a pure play data center business.” For more information on Hyperscale Data and its subsidiaries, Hyperscale...

Continue reading

Agillic’s CFO to leave

Announcement no. 09 2024 Copenhagen – 28 November 2024 – Agillic A/S Agillic’s CFO Claus Boysen has chosen to accept a new position outside Agillic and will leave the company on 28 February 2025. Christian Samsø says: It has been my pleasure to work with Claus and I would like to thank him for his efforts and contribution to Agillic through the years and I wish him the best in his future endeavours. For further information. please contact:Christian Samsø. CEO. Agillic A/S+45 24 88 24 24 Christian.samsoe@agillic.com Certified AdviserJohn Norden. Norden CEF A/S About Agillic A/S Agillic is a Danish software company offering brands a platform through which they can work with data-driven insights and content to create. automate and send personalised communication to millions. Agillic is headquartered in Copenhagen. Denmark. with teams in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.